Melanocortin-4 receptor expression in the cuneiform nucleus is involved in modulation of opioidergic signaling
Yong-Tang Song1, Tao-Tao Liu2, Li Feng2
1Medical Association of Hubei Province, Wuhan, 430060, China.
Abstract:
Substantial evidence has suggested that deep brain stimulation of the cuneiform nucleus has become a remarkable treatment option for intractable pain, but the possible mechanism is poorly understood. Using a melanocortin-4 receptor (MC4R)-green fluorescent protein (GFP) reporter knockin mouse, we showed that a large number of MC4R-GFP-positive neurons were expressed in the cuneiform nucleus. Immunofluorescence revealed that approximately 40%-50% of MC4R-GFP-positive neurons expressed mu opioid receptors, indicating that they were opioidergic signaling. Our findings support the hypothesis that MC4R expression in the cuneiform nucleus is involved in the modulation of opioidergic signaling.
Related Concept Videos
Opioid Receptors: Overview
Regulation of Food Intake
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Sympathetic Pathways: Collateral Ganglia and Adrenal Medulla
Collateral Ganglia
Sympathetic preganglionic axons reach the collateral ganglia along the route of splanchnic nerves. These nerves bypass the sympathetic trunk and communicate with sympathetic postganglionic neurons housed in the prevertebral ganglia. These ganglia supply the organs of the abdominopelvic cavity.
The greater splanchnic nerve, formed by the...
Opioid Analgesics: Synthetic and Semisynthetic Opioids


